EPIX

ESSA Pharma (EPIX)

ESSA Pharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:EPIX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/14	20 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EPIX	ESSA Pharma Inc
2024/05/14	20 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EPIX	ESSA Pharma Inc
2024/05/14	20 : 00	PR Newswire (US)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024	NASDAQ:EPIX	ESSA Pharma Inc
2024/05/14	20 : 00	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024	NASDAQ:EPIX	ESSA Pharma Inc
2024/05/07	06 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EPIX	ESSA Pharma Inc
2024/04/09	21 : 00	PR Newswire (Canada)	ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	NASDAQ:EPIX	ESSA Pharma Inc
2024/04/09	21 : 00	PR Newswire (US)	ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	NASDAQ:EPIX	ESSA Pharma Inc
2024/03/08	10 : 13	PR Newswire (Canada)	ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS	NASDAQ:EPIX	ESSA Pharma Inc
2024/03/08	10 : 13	PR Newswire (US)	ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS	NASDAQ:EPIX	ESSA Pharma Inc
2024/03/08	07 : 18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EPIX	ESSA Pharma Inc
2024/03/06	08 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EPIX	ESSA Pharma Inc
2024/02/13	21 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EPIX	ESSA Pharma Inc
2024/02/13	21 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EPIX	ESSA Pharma Inc
2024/02/13	21 : 00	PR Newswire (US)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023	NASDAQ:EPIX	ESSA Pharma Inc
2024/02/13	21 : 00	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023	NASDAQ:EPIX	ESSA Pharma Inc
2024/02/08	01 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EPIX	ESSA Pharma Inc
2024/02/06	22 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EPIX	ESSA Pharma Inc
2024/02/06	22 : 00	PR Newswire (US)	ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:EPIX	ESSA Pharma Inc
2024/02/06	22 : 00	PR Newswire (Canada)	ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/29	23 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/27	06 : 40	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/27	06 : 27	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/26	00 : 00	PR Newswire (Canada)	ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/26	00 : 00	PR Newswire (US)	ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers Symposium	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/24	06 : 09	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/18	10 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/17	06 : 19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/17	03 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/09	10 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EPIX	ESSA Pharma Inc
2024/01/06	06 : 04	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EPIX	ESSA Pharma Inc